NCT06672237Phase 3Active not recruiting

A Phase 3 Study of NTLA-2001 in ATTRv-PN

Study sponsor: Intellia Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-07Estimated
Enrollment · participants67Actual
Source updated2026-11-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 60 participants (planned). After: 67 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 2 fields changed

Planned enrollment increased by 10 participants

Before: 50 participants (planned). After: 60 participants (planned).

Recruitment status changed

Before: Active not recruiting. After: Recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview